跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FOSTAIR 200/6 beclometasone dipropionate 200 microgram and formoterol fumarate dihydrate 6 microgram pressurised inhalation solution - TGA Drug Approval Details
Approvals
/
TGA
/
FOSTAIR 200/6 beclometasone dipropionate 200 microgram and formoterol fumarate dihydrate 6 microgram pressurised inhalation solution
Approved
STANDARD
FOSTAIR 200/6 beclometasone dipropionate 200 microgram and formoterol fumarate dihydrate 6 microgram pressurised inhalation solution
Chiesi Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
964f8d4ae580a29a
Company
Chiesi Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
964f8d4ae580a29a
Product Name
FOSTAIR 200/6 beclometasone dipropionate 200 microgram and formoterol fumarate dihydrate 6 microgram pressurised inhalation solution
Artg Id
373934
Artg Name
FOSTAIR 200/6 beclometasone dipropionate 200 microgram and formoterol fumarate dihydrate 6 microgram pressurised inhalation solution
Sponsor
Chiesi Australia Pty Ltd
Company Detail Path
/organization/chiesi-australia-pty-ltd
Artg Date
2022-08-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/bf05be61c210d522f28945ce43870d11.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/69a5fe01ba2ac6575e6c28e95fcfa115.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
964f8d4ae580a29a
Type
Standard
Back to TGA Approvals